Results 31 to 40 of about 517 (142)

Identification of the Brucea javanica Constituent Brusatol as a EGFR-Tyrosine Kinase Inhibitor in a Cell-Free Assay

open access: yes, 2023
Inhibitors of the tyrosine kinase (TK) activity of the epidermal growth factor receptor (EGFR) are routinely used in cancer therapy. However, there is a need to discover a new TK inhibitor.
Agnes Mistlberger-Reiner   +19 more
core   +2 more sources

Correction: Pharmacokinetics and nephrotoxicity of cisplatin modulated by combination therapy with brusatol

open access: yesFrontiers in Pharmacology
Nan Guo   +5 more
doaj   +2 more sources

Dual effects of the Nrf2 inhibitor for inhibition of hepatitis C virus and hepatic cancer cells

open access: yesBMC Cancer, 2018
Background We previously showed that knockdown of nuclear factor E2-related factor 2 (Nrf2) resulted in suppression of hepatitis C virus (HCV) infection.
Yuko Murakami   +16 more
doaj   +1 more source

HPLC characterization of sorafenib, tamoxifen citrate, neratinib, gefitinib, cisplatin, oxaliplatin, cyclosporine A, methotrexate, topotecan, brusatol—chromatography conditions.

open access: yes, 2023
HPLC characterization of sorafenib, tamoxifen citrate, neratinib, gefitinib, cisplatin, oxaliplatin, cyclosporine A, methotrexate, topotecan, brusatol—chromatography conditions.
Di Zhao (302432)   +9 more
core   +1 more source

Brusatol Suppresses Bladder Cancer by downregulating the expression of Nrf2

open access: yes, 2022
Abstract A substance called brunsatol, which is derived from the dried ripe fruit of Brucea javanica, has been shown to be active against a variety of human cancers, but not against bladder cancer (BCa). In the present study, we attempted to investigate the effect of brusatol in BCa and verify whether Nrf2 was involved in the mechanism.
Xi Yu   +5 more
openaire   +1 more source

Brusatol Derivative–34 Attenuates Allergic Airway Inflammation Via Inhibition of the Spleen Tyrosine Kinase Pathway

open access: yesFrontiers in Pharmacology, 2021
Brusatol derivative-34 (Bru-34), a derivative of brusatol, has been shown significantly anti-inflammatory activity in mice in our previously work. However, to our knowledge, there were very limited studies on how Bru-34 affected airway inflammation. Thus,
Yasi Ding   +8 more
doaj   +1 more source

Brusatol Inhibits Tumor Growth and Increases the Efficacy of Cabergoline against Pituitary Adenomas [PDF]

open access: yesOxidative Medicine and Cellular Longevity, 2021
Cabergoline (CAB) is the first choice for treatment of prolactinoma and the most common subtype of pituitary adenoma. However, drug resistance and lack of effectiveness in other pituitary tumor types remain clinical challenges to this treatment. Brusatol (BT) is known to inhibit cell growth and promote apoptosis in a variety of cancer cells.
Zerui Wu   +7 more
openaire   +2 more sources

Effects of grape seed proanthocyanidin B2 pretreatment on oxidative stress and renal tubular epithelial cell apoptosis after renal ischemia reperfusion in mice [PDF]

open access: yesActa Cirúrgica Brasileira, 2020
Purpose To investigate the effects of grape seed proanthocyanidin B2 (GSPB2) preconditioning on oxidative stress and apoptosis of renal tubular epithelial cells in mice after renal ischemia-reperfusion (RIR).
Zhi-shun Wang   +4 more
doaj   +1 more source

Abstract 5407: Targeting NRF2 using specific inhibitor brusatol sensitized esophageal adenocarcinoma cells to cisplatin through inducing ferroptosis

open access: yes, 2022
Background: The incidence rate of the esophageal adenocarcinoma (EAC) has increased rapidly among men during the past four decades in the USA and western countries while the 5 year survival rate is still below 20%.
Zhu, Shoumin   +11 more
core   +1 more source

Brusatol Enhances the Chemotherapy Efficacy of Gemcitabine in Pancreatic Cancer via the Nrf2 Signalling Pathway

open access: yes, 2018
Although gemcitabine is the standard chemotherapy treatment for advanced pancreatic cancer, its benefits are quite limited due to prevalent chemoresistance, and the mechanism underlying gemcitabine chemoresistance remains unclear.
Chaohao Huang   +11 more
core   +1 more source

Home - About - Disclaimer - Privacy